Optimal EPO dosing in hemodialysis patients using a non-linear model predictive control approach
Crossref DOI link: https://doi.org/10.1007/s00285-019-01429-1
Published Online: 2019-10-19
Published Print: 2019-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rogg, S. http://orcid.org/0000-0002-9083-4329
Fuertinger, D. H.
Volkwein, S.
Kappel, F.
Kotanko, P.
Funding for this research was provided by:
Renal Research Institute New York, New York, USA
Text and Data Mining valid from 2019-10-19
Version of Record valid from 2019-10-19
Article History
Received: 13 January 2018
Revised: 6 September 2019
First Online: 19 October 2019